Skip to main content
. 2017 Apr 28;23:166–172. doi: 10.12659/MSMBR.901576

Figure 2.

Figure 2

In vivo assessment of the anti-cancer functions of alginate particles carrying OVA peptide in a B-16 OVA mouse tumor model. Four groups of mice were used in this study: Control (mice with no treatment), NP (mice treated with alginate nanoparticles), OVA in soluble form (mice treated with soluble OVA), and NP/OVA (mice treated with alginate particles carrying OVA). (A) Tumor size over time in the 4 groups of mice. (B) Survival curve of the 4 groups of mice.